Cardiovascular Featured Articles

  1. Finding The Right CRO For Rare Disease Trials

    CRO selection is a challenge for every company outsourcing clinical trials. When the trial you are about to launch is for a rare genetic disease and has 30 patients spread across multiple countries and continents, the challenges are multiplied. This was the situation for Cerenis Therapeutics, which recently launched a Phase 3 trial for patients having very low levels of high-density lipoprotein.

  2. Duke & PCORI Use EHRs To Transform Clinical Trials

    PCORI (Patient-Centered Outcomes Research Institute) and the Duke Clinical Research Institute have launched the ADAPTABLE study, a patient-centric trial designed to assess the benefits and long-term effectiveness of aspirin dosing. With a budget of over $14 million, the trial will randomize and dose 20,000 patients while leveraging health systems, EHRs (electronic health records), and patients in an attempt to fundamentally transform clinical research.

  3. William Daley Joins Clinical Leader Editorial Advisory Board

    Dr. William Daley, VP of Medical Affairs at Sanofi-Aventis, has agreed to join the Editorial Advisory Board for Clinical Leader. Daley's research interests are in the field of vascular biology and thrombosis as it pertains to lipid metabolism, diabetes, hypertension, coronary blood flow, cardiovascular disease, women's health and the therapeutic applications of information technology.